Breast-Conserving Surgery

Introduction

If you have been diagnosed with early-stage breast cancer, one of the first major decisions you will face with your surgical team is the choice of operation. For many patients, breast-conserving surgery — often called a lumpectomy — is one of the main options. It removes the cancer along with a small rim of normal tissue while keeping most of the breast intact.

Over the last four decades, large clinical trials have shown that for suitable patients with early breast cancer, breast-conserving surgery followed by radiation therapy provides long-term survival similar to mastectomy (removal of the whole breast). Because of this, major cancer organisations including the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) describe breast-conserving surgery as a standard treatment option for early-stage disease.

This article explains what breast-conserving surgery involves, who it is suitable for, what the alternatives are, how the operation is performed, what recovery looks like, what risks to expect, and what life after the operation typically involves. It is written for patients who already have a diagnosis and are planning the next steps with their oncology team.

What Is Breast-Conserving Surgery?

Breast-conserving surgery is an operation that removes a breast cancer along with a margin of surrounding normal tissue, while leaving the rest of the breast in place. The medical literature uses several names for essentially the same operation:

• Lumpectomy — the most common name used by patients and doctors
• Wide local excision — the term used in many surgical textbooks, especially in the UK
• Partial mastectomy — used when a larger segment of breast tissue is removed
• Quadrantectomy — an older term for removal of a quadrant of the breast

The goal of the operation is to remove all of the cancer with what surgeons call “clear margins.” A clear margin means that when the removed tissue is examined under the microscope, there are no cancer cells at the cut edge. The current consensus from ASCO, SSO, and ASTRO (the American oncology societies) defines a clear margin as “no ink on tumour” for invasive breast cancer, and a 2 mm margin for ductal carcinoma in situ (DCIS).

Breast-conserving surgery is almost always part of a broader treatment plan. For most patients, it is followed by radiation therapy to the remaining breast tissue to reduce the chance of the cancer coming back in the same breast. Depending on the tumour’s features, additional treatments such as hormone therapy, chemotherapy, or targeted therapy may also be part of the plan.

Why Is Breast-Conserving Surgery Performed?

Breast-conserving surgery is performed to treat breast cancer in a way that removes the disease while preserving the shape, sensation, and appearance of the breast as much as possible. It is typically used for:

• Early-stage invasive breast cancer (Stage I and Stage II), where the tumour is relatively small and confined to one area
• Ductal carcinoma in situ (DCIS), a non-invasive form of breast cancer where abnormal cells are contained within the milk ducts
• Selected larger tumours that have been shrunk by chemotherapy given before surgery (this is called neoadjuvant chemotherapy)
• Some cases of lobular carcinoma in situ (LCIS) with an associated invasive component

The decision to perform breast-conserving surgery rather than mastectomy is based on several factors, including the size of the tumour relative to the breast, the position of the tumour, whether there is more than one tumour, the patient’s overall health, and the patient’s own preferences after a thorough discussion of options.

Who Is a Candidate?

Doctors typically consider breast-conserving surgery when several conditions are met. These include:

• The tumour is small relative to the size of the breast, so it can be removed with clear margins without significantly distorting the breast
• The cancer is in one area of the breast (unifocal disease), rather than being spread across multiple separate regions
• The patient is medically fit for surgery
• Radiation therapy can be given safely afterwards
• The patient prefers to keep the breast, after understanding both options

Breast-conserving surgery may not be suitable, or may carry a higher risk of recurrence, in the following situations:

• The tumour is large relative to the breast, so removing it would leave little breast tissue or significant deformity
• There are multiple separate tumours in different parts of the same breast (multicentric disease)
• The patient has had previous radiation therapy to the same breast or chest area, so further radiation cannot be safely given
• The patient has certain connective tissue diseases (such as active scleroderma) that make radiation therapy unsafe
• Clear surgical margins cannot be achieved despite repeat surgery
• The patient is pregnant in the first or second trimester, when radiation therapy cannot be delivered (though surgery may still be possible, with radiation delayed until after delivery)
• Certain inherited gene mutations (such as BRCA1 or BRCA2) where the patient may choose mastectomy because of the higher lifetime risk of new cancers

For patients with BRCA1, BRCA2, or other high-risk gene mutations, mastectomy is one option that some patients choose because of the elevated future risk in remaining breast tissue. However, breast-conserving surgery is not ruled out by genetic status alone, and this is a discussion that genetic counsellors and the oncology team will have with the patient.

Alternatives to Breast-Conserving Surgery

The main surgical alternative to breast-conserving surgery is mastectomy. There are also non-surgical options in specific situations. Understanding these alternatives is important for an informed choice.

Mastectomy

Mastectomy is the surgical removal of the entire breast. There are several variants:

• Simple (total) mastectomy — removes all of the breast tissue but leaves the chest muscles and most of the lymph nodes
• Skin-sparing mastectomy — removes the breast tissue while keeping most of the skin, allowing for immediate reconstruction
• Nipple-sparing mastectomy — preserves the skin, nipple, and areola; suitable in selected cases
• Modified radical mastectomy — removes the breast and most of the axillary (armpit) lymph nodes

Mastectomy is often chosen when breast-conserving surgery is not suitable, or when the patient prefers it after discussing the options. For early-stage disease where both operations are options, multiple long-term trials — including NSABP B-06 and the Milan trials — have shown that breast-conserving surgery followed by radiation gives survival outcomes similar to mastectomy. The choice often comes down to the specific tumour features, the breast anatomy, the willingness to receive radiation, and the patient’s own values.

Mastectomy with reconstruction

If mastectomy is chosen, breast reconstruction can be performed either at the same time (immediate reconstruction) or later (delayed reconstruction). Reconstruction uses either implants or tissue taken from another part of the body (autologous reconstruction). The plastic surgery team and the breast surgeon plan this together.

Neoadjuvant therapy to enable breast conservation

For some patients whose tumour would initially be too large for breast-conserving surgery, chemotherapy, hormone therapy, or targeted therapy can be given first to shrink the tumour. If the tumour responds well, breast-conserving surgery may then become possible. This is particularly common in HER2-positive and triple-negative cancers.

Active surveillance

Breast-conserving surgery is not a single, uniform procedure. Several techniques may be used depending on the tumour location, the breast size, and whether the tumour is easy to feel.

Standard lumpectomy

This is the most straightforward approach. The surgeon makes an incision over or near the tumour, removes the tumour with a rim of normal tissue, and closes the wound. It is suitable for tumours that are easily felt and where the breast tissue can be closed without distortion.

Oncoplastic breast-conserving surgery

Oncoplastic surgery combines cancer surgery with plastic surgery principles. After the tumour is removed, the remaining breast tissue is reshaped to maintain a natural appearance. In some cases, the other breast is also operated on (for example, a reduction) to keep both breasts symmetrical. Oncoplastic techniques are particularly useful when:

• The tumour is in a location where standard removal would cause noticeable distortion (such as the inner or lower portion of the breast)
• The amount of tissue to be removed is relatively large compared with the breast size
• The patient has large or pendulous breasts where reduction can be performed at the same time

The American Society of Breast Surgeons and other professional bodies have published guidance describing oncoplastic surgery as a valuable extension of breast-conserving surgery in appropriate cases. It can allow breast conservation in patients who might otherwise have needed a mastectomy.

Image-guided lumpectomy

When the tumour cannot be easily felt — for example, when it was found on screening mammography but is not palpable — the surgeon needs help locating it precisely. Several techniques are used:

• Wire localisation — a thin wire is placed into the tumour under mammographic or ultrasound guidance before surgery, and the surgeon follows the wire to the tumour
• Radioactive seed localisation — a tiny radioactive marker is placed in the tumour beforehand, and the surgeon uses a probe to locate it during surgery
• Magnetic or radiofrequency markers — newer non-wire systems that work on similar principles
• Intraoperative ultrasound — the surgeon uses an ultrasound probe during the operation to locate the tumour

Sentinel lymph node biopsy

For most patients with invasive breast cancer, the surgeon will also check the lymph nodes in the armpit (axilla) to see whether the cancer has spread. The standard approach for early-stage disease is sentinel lymph node biopsy, in which only the first one or two lymph nodes that drain the breast are removed and tested. A dye or radioactive tracer (or both) is injected into the breast before surgery to identify these nodes.

If the sentinel nodes are clear, no further lymph node surgery is usually needed. If they contain cancer, the management decision — whether to remove more nodes or to treat them with radiation — depends on the specific findings and current guidelines, including the influential Z0011 trial results which have changed practice for many patients.

Robotic and minimally invasive approaches

Unlike many other cancer surgeries, breast-conserving surgery is not typically performed with robotic or laparoscopic techniques in standard practice. The breast is a surface organ and is accessed directly. Some centres are investigating endoscopic and robotic mastectomy techniques, but these are not standard for breast conservation.

Preparing for Surgery

Before breast-conserving surgery, your team will complete a number of evaluations to confirm the diagnosis, plan the surgery, and assess your overall fitness.

Imaging and diagnostic tests

• Mammography — usually both breasts
• Breast ultrasound — to assess the tumour and check the axillary lymph nodes
• Breast MRI — in selected cases, such as dense breasts, lobular cancers, or when the extent of disease is unclear
• Core needle biopsy — to confirm the diagnosis and obtain tissue for receptor testing
• Receptor and biomarker testing — oestrogen receptor (ER), progesterone receptor (PR), and HER2 status, which guide systemic treatment decisions
• Staging tests — for higher-risk tumours, additional imaging such as a CT scan or bone scan may be done to check for spread

Multidisciplinary planning

Most breast cancers are discussed in a multidisciplinary tumour board, where surgical oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists review the case together. This is the setting in which the recommended sequence of treatments — surgery first, or chemotherapy first — is decided.

Pre-operative assessment

• Blood tests, including a full blood count and basic chemistry
• An electrocardiogram (ECG) and chest X-ray, especially in older patients or those with heart or lung conditions
• Anaesthesia review to identify any factors that affect the choice of anaesthetic
• A discussion of medications, particularly blood thinners, that may need to be stopped before surgery

Practical preparation

You will usually be asked to fast for several hours before the operation, to arrange someone to drive you home after discharge, and to wear loose, front-opening clothing on the day of surgery. The team will also discuss what to expect from the incision, any drains, and the early recovery period.

What Happens During the Operation

Breast-conserving surgery is most commonly performed under general anaesthesia, although in some cases a combination of sedation and local or regional anaesthesia may be used. The operation typically takes between one and two hours, and longer if sentinel lymph node biopsy and oncoplastic reshaping are also performed.

1. If a wire or marker was placed earlier for non-palpable tumours, the surgeon uses this to locate the tumour
2. If a sentinel lymph node biopsy is planned, dye and/or a radioactive tracer is injected into the breast either before or during the operation
3. An incision is made, usually positioned to allow the best cosmetic result, often along natural skin lines or at the edge of the areola where possible
4. The tumour is removed along with a margin of surrounding normal tissue
5. If sentinel lymph node biopsy is planned, the sentinel nodes are identified and removed
6. The removed tissue is marked with sutures or clips so the pathologist can orient it and assess all margins
7. In some centres, the tissue is X-rayed in the operating room (specimen radiography) to confirm that the suspicious area has been removed
8. If oncoplastic techniques are being used, the remaining breast tissue is reshaped to restore contour
9. The wound is closed in layers, usually with dissolvable stitches, and a dressing is applied

The full pathology report — including final margin status, tumour grade, and lymph node findings — usually takes several days to a week. Sometimes, if the final margins come back positive (cancer cells at the edge), a second operation called a re-excision is needed to remove additional tissue. This happens in a small percentage of cases and does not change long-term outcomes when corrected.

Recovery and Healing

Recovery from breast-conserving surgery is generally faster than from mastectomy. Many patients go home the same day or after an overnight stay.

The first few days

• Mild to moderate soreness and bruising at the surgical site, controlled with simple painkillers
• A dressing over the wound, usually changed at the first follow-up visit
• Instructions to keep the area clean and dry and to watch for signs of infection
• Light activities are usually possible within a day or two; rest is advised but full bed rest is not

The first few weeks

• Most patients return to routine daily activities within one to two weeks
• Driving is usually resumed when you can comfortably perform an emergency stop and are off strong painkillers
• Return to work depends on the type of work — desk-based work is often possible within one to two weeks; physically demanding work may take longer
• Gentle shoulder and arm exercises help maintain mobility, particularly if axillary surgery was performed
• Heavy lifting and strenuous exercise are usually avoided for several weeks

The first few months

Radiation therapy, if planned, usually starts within three to eight weeks of surgery, once the wound has healed. A typical course of whole-breast radiation lasts three to four weeks, although shorter courses (hypofractionated radiation) and accelerated partial-breast irradiation are now used in many suitable patients. Fatigue and skin changes are the most common side effects during radiation.

Emotional recovery

Recovery is not only physical. Many patients describe a complex mix of relief, anxiety about recurrence, fatigue, and changes in body image. Talking openly with the oncology team, a breast care nurse, or a counsellor can help. Peer support groups and patient organisations are also valuable resources.

Risks and Complications

Breast-conserving surgery is generally a safe operation, and serious complications are uncommon. However, like all surgery, it carries some risks. Understanding them in advance helps you recognise problems early.

Short-term risks

• Bleeding or haematoma — a collection of blood in the surgical area, which sometimes needs drainage
• Infection — usually treated with antibiotics
• Seroma — a collection of clear fluid, which may need to be drained if it becomes uncomfortable
• Pain — typically mild to moderate and well-controlled with oral painkillers
• Reactions to the anaesthetic — rare but possible

Longer-term effects

• Changes in breast appearance — the operated breast may end up slightly smaller, firmer, or differently shaped, particularly after radiation
• Changes in sensation — numbness or altered feeling around the scar and sometimes in the nipple
• Scarring — the appearance of the scar varies between patients and locations
• Lymphoedema — swelling of the arm on the same side, mostly related to lymph node surgery and radiation rather than to the breast surgery itself; the risk is lower with sentinel node biopsy than with full axillary clearance
• Shoulder stiffness — particularly if axillary surgery was performed; usually improves with exercise and physiotherapy
• Cording (axillary web syndrome) — tight, rope-like bands of tissue under the arm; usually self-limiting and helped by stretching and physiotherapy

Risk of local recurrence

The most important oncological risk is local recurrence — the cancer returning in the same breast. With modern surgery and radiation therapy, the risk of local recurrence at ten years is low for most patients with early-stage disease. Factors that influence this risk include the tumour’s biological features, the margin status, the patient’s age, and whether all recommended treatments are completed. Regular follow-up imaging is designed to detect recurrence early if it does occur.

Adjuvant Treatments After Surgery

Breast-conserving surgery is rarely the only treatment. The combination of surgery and other therapies is what gives modern breast cancer treatment its strong long-term results. The specific adjuvant treatments depend on the tumour features.

Radiation therapy

For most patients who have had breast-conserving surgery, radiation therapy to the remaining breast tissue is part of standard care. It reduces the risk of cancer coming back in the same breast. Several radiation schedules exist, including:

• Whole-breast radiation — the traditional approach, typically over three to six weeks
• Hypofractionated radiation — shorter courses with slightly higher daily doses, now widely used and supported by long-term trial evidence
• Accelerated partial-breast irradiation — radiation focused on the area where the tumour was removed, in selected low-risk cases
• Intraoperative radiation therapy — a single dose of radiation given during the operation, available in some centres for selected patients

For some older patients with small, low-risk, hormone-receptor-positive tumours, radiation may sometimes be omitted in favour of hormone therapy alone, based on individual risk discussion and current guidelines.

Hormone (endocrine) therapy

If the cancer is hormone receptor positive (ER and/or PR positive), hormone therapy is usually given for at least five years, sometimes longer. Common options include tamoxifen and aromatase inhibitors. The choice depends on menopausal status and other factors.

Chemotherapy

Chemotherapy is considered when the tumour has features that suggest a higher risk of spread — for example, larger size, lymph node involvement, certain biological subtypes (triple-negative, HER2-positive), or a high score on a genomic test such as Oncotype DX or MammaPrint. Genomic tests help identify patients who will and will not benefit from chemotherapy.

Targeted therapy

For HER2-positive cancers, targeted drugs such as trastuzumab (and others) are part of standard care, usually given for a year. Other targeted therapies are used in specific situations.

Sequencing of treatments

The order in which these treatments are given is planned by the multidisciplinary team. In many cases, the sequence is: surgery, then chemotherapy (if needed), then radiation, then hormone therapy. In some cases, chemotherapy is given before surgery (neoadjuvant) to shrink the tumour and improve surgical options.

Life After Breast-Conserving Surgery

Most patients return to their pre-treatment routines over the course of several months, although the recovery from systemic therapies (chemotherapy in particular) can take longer.

Follow-up care

Long-term follow-up is an important part of survivorship care. A typical follow-up schedule includes:

• Clinical examinations every three to six months for the first few years, then annually
• Annual mammography of both breasts (some patients may also have additional imaging such as breast MRI based on risk)
• Ongoing review of hormone therapy if prescribed
• Monitoring for late side effects of treatment, including bone health on aromatase inhibitors and cardiac health after certain chemotherapies

Physical activity and lifestyle

Evidence consistently links regular physical activity to better outcomes after breast cancer, including lower recurrence risk and better quality of life. Maintaining a healthy weight, limiting alcohol, not smoking, and a balanced diet are all part of survivorship guidance from major oncology societies.

Body image, intimacy, and emotional health

Changes in breast appearance, sensation, or symmetry can affect body image and intimacy. These are normal concerns and worth raising with your team. Options ranging from prosthetic adjustments to delayed cosmetic procedures may be available, and counselling support is increasingly recognised as an important part of breast cancer care.

Fertility and pregnancy

For younger patients, fertility-related questions often arise. Chemotherapy and hormone therapy can affect fertility and pregnancy planning. These issues are ideally discussed before starting treatment, and fertility preservation options may be considered. Pregnancy after breast cancer is possible for many patients and is discussed in detail with the oncology team.

Returning to work and daily life

Most patients are able to return to work and normal activities, though the pace varies depending on the type of work, the treatments received, and individual recovery. Open conversations with employers and gradual return-to-work plans often help.

Frequently Asked Questions

How long does the operation take?

A standard lumpectomy usually takes about one to two hours. If sentinel lymph node biopsy and oncoplastic reshaping are also performed, the operation may take longer.

Will I need a second operation?

In a small percentage of cases, the final pathology shows cancer cells at the edge of the removed tissue. When this happens, a second, smaller operation called a re-excision is performed to remove a little more tissue. Long-term outcomes are not affected when this is done.

Do I always need radiation after breast-conserving surgery?

For most patients, radiation therapy after breast-conserving surgery is part of standard care because it significantly reduces the risk of cancer returning in the same breast. In some older patients with very low-risk, hormone-sensitive cancers, omitting radiation may be considered after a careful discussion of risks and benefits. Whether radiation is right in any particular case is a decision made with the radiation oncologist.

Is survival the same as with mastectomy?

Long-term studies, including landmark trials such as NSABP B-06 and the Milan trials, have shown that for suitable patients with early-stage breast cancer, breast-conserving surgery combined with radiation therapy gives survival outcomes similar to mastectomy. The choice between the two operations is therefore based on tumour characteristics, breast anatomy, and patient preference rather than survival alone.

What does “clear margins” mean?

It means that when the removed tissue is examined under the microscope, the edges are free of cancer. For invasive breast cancer, the current standard is “no ink on tumour,” meaning no cancer cells touch the inked edge of the specimen. For DCIS, a 2 mm clear margin is the standard. These definitions come from joint guidance by the American oncology societies (ASCO, SSO, and ASTRO).

Will my breast look the same afterwards?

The appearance of the breast after surgery and radiation varies. Most patients have some change in shape, size, firmness, or sensation. Oncoplastic techniques aim to maintain the natural shape and symmetry. Final cosmetic results often continue to settle over a year or more, as radiation effects mature.

Can I have reconstruction after breast-conserving surgery?

The term “reconstruction” usually refers to rebuilding the breast after mastectomy. After breast-conserving surgery, the focus is on preserving and reshaping the existing breast. If the appearance is significantly different from the other side, further procedures such as fat grafting or surgery on the other breast for symmetry may be discussed later.

What about lymphoedema?

Lymphoedema (swelling of the arm) is mostly related to lymph node surgery and radiation rather than to the breast operation itself. The risk is much lower with sentinel lymph node biopsy than with full axillary lymph node removal. Early signs include arm heaviness or tightness; if you notice these, contact your team.

How often will I need follow-up imaging?

After breast-conserving surgery, annual mammography of both breasts is standard. Some patients with higher risk may also have breast MRI. The exact schedule is set by your oncology team and may evolve over time.

Can the cancer come back?

There is a small risk of recurrence either in the same breast, the other breast, the lymph nodes, or elsewhere in the body. With modern combined treatment, this risk is low for most patients with early-stage disease. Regular follow-up is designed to detect any recurrence early, when it is most treatable.

Conclusion

Breast-conserving surgery has been one of the most significant changes in breast cancer treatment over the past half-century. For many patients with early-stage disease, it offers a way to treat the cancer effectively while keeping the breast. Combined with radiation therapy and, where indicated, hormone therapy, chemotherapy, or targeted therapy, it provides long-term outcomes similar to mastectomy in appropriate candidates.

The decision between breast-conserving surgery and mastectomy is not just a medical calculation. It depends on tumour features, breast anatomy, personal values, and the input of a multidisciplinary team that includes surgical oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists. Understanding what the operation involves, what alternatives exist, and what to expect during recovery is an important part of having an informed conversation with your team and making the choice that is right for you.